Ligand validation:4XDL

PC1: 1,2-DIACYL-SN-GLYCERO-3-PHOSPHOCHOLINE

PC1 is a Ligand Of Interest in 4XDL designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4XDL_PC1_D_403	9%	98%	0.221	0.866	0.17	0.12	-	-	0	0	15%	14.81
4XDL_PC1_D_402	7%	97%	0.273	0.887	0.22	0.12	-	-	0	0	17%	16.669999999999998
4XDL_PC1_A_606	1%	97%	0.355	0.648	0.21	0.11	-	-	0	0	15%	14.81
4XDL_PC1_A_603	0%	95%	0.739	0.41	0.28	0.13	-	-	0	0	20%	0.2037
4XDK_PC1_B_401	4%	97%	0.301	0.82	0.18	0.14	-	-	1	0	20%	0.2037
3WGU_PC1_A_2011	62%	45%	0.128	0.919	0.92	1.21	4	5	3	0	100%	1
3WGV_PC1_A_2011	51%	42%	0.141	0.893	0.94	1.32	4	6	1	0	100%	1
3AYN_PC1_B_1004	42%	35%	0.116	0.885	1.62	0.98	3	1	1	0	72%	0.7222
2Z73_PC1_B_1004	29%	34%	0.182	0.889	1.64	0.97	2	1	1	0	72%	0.7222
3EAM_PC1_E_601	25%	24%	0.202	0.863	1.43	1.69	4	6	0	1	87%	0.8704

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.